Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer cover art

Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

Listen for free

View show details

About this listen

 Great new insights in the Optimum Perspectives' latest podcast edition featuring Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics, about the growing role of B cell technology in cancer therapy.

Hosted on Acast. See acast.com/privacy for more information.

What listeners say about Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.